← ANALYSTS · TIPRANKS
Elemer Piros · Lucid Capital
Hits
35%
170 of 481 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
−8.3%
Over a year after the rating, TipRanks’ measure
Our companies rated now
2
Buy / hold / sell: 2 / 0 / 0
Upside of the analyst’s targets
+1,876.3%
Average over 2 current targets, to the last price
The market’s answer to the ratings
+12.7%
Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Apr 15on TipRanks 06:15 | NGENNervGen Pharma · $205M | Initiated | Buy | $18.00 | +1,032.1% | +0.4%next day −2.1% · 5 days −6.7% | ↗ |
| Mar 11on TipRanks Mar 12 01:13 | OCGNIWMOcugen · $276M | Reiterated | Buy | $15.00 → $22.00+46.7% | +2,720.5% | +30.1%next day +3.3% · 5 days +1.8% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗